Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : For save search
EZGO Enters into an RMB13 Million Procurement Agreement for Sale of Security Patrol Robots and Platform
Published: 2024-04-12 (Crawled : 12:00) - prnewswire.com
EZGO | $1.965 3.42% 3.31% 420K
|
|
| O: 4121.7%
H: 0.0%
C: 0.0%
rmb13 patrol million security for agreement platform
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
ADIL | $1.9 -12.44% -14.21% 310K
|
Health Technology
|
| O: 123.48%
H: 0.0%
C: 0.0%
ad04 alcohol publication treatment pharmaceuticals for trial potential
Company Provides Operational Update for Monterey County Oil Producing Assets
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
TPET | $0.3975 21.23% -2.19% 50M
|
n/a
|
| O: 104.41%
H: 12.98%
C: -9.41%
company update for oil
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
SNGX | $0.4233 -2.76% -2.83% 1M
|
Health Technology
|
| O: 75.34%
H: 37.73%
C: -30.58%
fda drug marburg infection designation for grants
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
ONVO | $1.11 -3.48% -3.6% 280K
|
Health Technology
|
| O: 64.34%
H: 4.82%
C: -18.67%
fxr314 metabolic liver positive for results
U Power To Launch Commercial Operation for its EV Battery Swapping System
Published: 2024-04-08 (Crawled : 10:00) - prnewswire.com
UCAR | $5.09 0.39% 0.39% 92K
|
|
| O: 56.35%
H: 9.52%
C: -31.85%
battery system for commercial
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
LGVN 1 d | $1.93 -3.98% -4.15% 460K
|
|
| O: 41.42%
H: 42.68%
C: 22.59%
conference disease association alzheimer’s presentation international research for trial
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
NBY | $0.0824 -1.91% 0.0% 1.6M
|
Health Technology
|
| O: 38.7%
H: 0.0%
C: -20.0%
sales first revenue care pharmaceuticals for
Edible Garden Reports Preliminary First Quarter Year-Over-Year Increase in Produce Revenues of 40%; Cut Herb Revenue Increased More Than 200% for the Same Period
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
EDBL | $3.89 -15.07% -17.74% 360K
|
|
| O: 37.58%
H: 0.0%
C: 0.0%
first revenue for
Future Pak Confirms Proposal to Acquire Vanda Pharmaceuticals for $7.25 to $7.75 Per Share in Cash
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
MC | $51.65 1.33% 0.0% 590K
|
Finance
|
| O: 0.56%
H: 0.8%
C: -0.41%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 35.5%
H: 4.61%
C: -3.32%
pharmaceuticals acquire for proposal
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JAGX | $0.158 -10.79% -12.09% 30M
|
Health Technology
|
| O: 26.26%
H: 73.2%
C: 18.87%
health cancer care for commercial
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Published: 2024-04-11 (Crawled : 13:00) - globenewswire.com
CADL | $5.17 -5.31% -5.61% 520K
|
|
| O: 25.49%
H: 23.75%
C: 13.75%
can-2409 fda drug cancer pancreatic treatment designation for therapeutics
Smart for Life Announces Definitive Agreement to Acquire Purely Optimal Nutrition, a Premier North American Nutraceutical Company
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
SMFL | $0.481 4.0% 3.85% 3M
|
Manufacturing
|
| O: 23.56%
H: 100.32%
C: 11.06%
company life acquire for smart agreement
Smart for Life Releases Corporate Video on Definitive Agreement to Acquire Purely Optimal Nutrition
Published: 2024-04-08 (Crawled : 17:00) - globenewswire.com
SMFL | $0.481 4.0% 3.85% 3M
|
Manufacturing
|
| O: 23.56%
H: 100.32%
C: 11.06%
nutrition life acquire for smart agreement
Red Cat Announces Agreement with Sentien Robotics UAS Hive for Land, Air and Sea Drone Swarming Operations
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
RCAT | $1.1 3.77% 3.64% 940K
|
Information
|
| O: 20.17%
H: 0.0%
C: 0.0%
cat air for agreement
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
Published: 2024-04-09 (Crawled : 21:00) - globenewswire.com
MDNAF | $1.24 -17.54% 67K
|
n/a
|
| O: 18.35%
H: 13.64%
C: 12.4%
mdna11 association cancer ongoing expansion research for meeting results study
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
MDNAF | $1.24 -17.54% 67K
|
n/a
|
| O: 18.35%
H: 13.64%
C: 12.4%
mdna11 association cancer ongoing expansion research for meeting results study
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
Published: 2024-04-05 (Crawled : 12:00) - globenewswire.com
TARA | $2.62 -4.73% -4.96% 210K
|
Health Technology
|
| O: 16.92%
H: 11.06%
C: -22.77%
fda nutrition for therapeutics
PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions
Published: 2024-04-09 (Crawled : 13:00) - globenewswire.com
PRFX 1 d | $0.8737 -1.83% -1.87% 29K
|
Health Technology
|
| O: 15.88%
H: 29.44%
C: -23.35%
treatment for
Todays' Top-5
Bright Scholar Announces Unaudited Financial Results for the Second Quarter of Fiscal 2024
Published: 2024-04-19 (Crawled : 11:00) - prnewswire.com
BEDU | News | $2.01 6.92% -4.98% 18K
|
Commercial Services
|
| O: 13.4%
H: 0.0%
C: 0.0%
for financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.